January 31, 2024
NMDP BioTherapies, formerly Be The Match BioTherapies, announced Tuesday that Tom Hochuli, MBA, will serve as the organization’s next president. Before joining NMDP BioTherapies, Hochuli served as CEO of Current Biologics, a startup company focused on providing cell and gene therapy manufacturing and development services, and as CEO of Vibalogics, a virotherapy process development and manufacturing organization. Hochuli has also served several biotherapies organizations as principal consultant, advisor and board member. He will report to NMDP’s CEO, Amy Ronneberg.